Red blood cell entrapment in thrombi formed under pathological flow: Stiffness and binding antigens impact thrombus

Anjana Jayaraman1, Junhyuk Kang2, Purvil Jani1

  • 1Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, USA.

Acta Biomaterialia
|May 25, 2025
PubMed

Thrombosis, or pathological blood clot formation, is a dangerous and potentially fatal event that is often associated with implanted medical devices. Thrombi are comprised of platelets, plasma proteins, red blood cells (RBCs) and other molecular and cellular components. Extensive research has been conducted on the dynamics of platelet aggregation and deposition; however, the process of RBC entrapment remains under-explored. In this study, we used a microfluidic device and fluorescence microscopy to concurrently image platelets and RBCs during thrombus formation under flow and biomaterial conditions representative of implanted devices. We designed and applied MATLAB algorithms to track thrombi as they grew over time and interrogated thrombus growth and RBC accumulation trends. To probe the contributions of the unique mechanical properties of RBCs, we characterized the influence of induced RBC stiffness on thrombus forming behavior via imaging. To study the binding effects of known RBC surface antigens, we visualized thrombus formation with inhibition of glycoprotein (GP) IIb/IIIa and integrin-associated protein (IAP) respectively. We found that the accumulation and clustering of RBCs within the thrombi exhibited an inverse relationship with stiffness. Fibrillar structures were also present in these thrombi. Stiff RBCs enhanced platelet aggregate growth in all directions. Inhibition of surface binding proteins GPIIb/IIIa and IAP decreased the stability of thrombi. The results show that RBC deformability impacts entrapment location, fibril growth and spatial distribution. In turn, RBC binding stabilizes and anchors aggregates to surfaces. These findings will inform improved device design and multi-phase models of thrombosis that incorporate RBCs. STATEMENT OF SIGNIFICANCE: Thrombosis, the pathological formation of blood clots, is linked to cardiovascular disease and implanted devices. This study explores the mechanisms by which red blood cells (RBCs) become trapped in clots and their impact on clot properties. Using a microfluidic model, we show that RBC stiffness affects their accumulation and distribution within thrombi, influencing thrombus structure and composition. We also find that RBC surface proteins, such as GPIIb/IIIa and integrin-associated protein, contribute to thrombus stability. These findings will enhance thrombosis models and inform research on the interaction between biomaterials, including blood-contacting devices, and biological systems at the cellular and molecular levels.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
47
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
934
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.2K